Avalo Therapeutics Inc (AVTX)
9.50
-0.14
(-1.45%)
USD |
NASDAQ |
May 17, 16:00
9.50
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Free Cash Flow: -30.68M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.68M |
| September 30, 2023 | -31.85M |
| June 30, 2023 | -19.33M |
| March 31, 2023 | -20.99M |
| December 31, 2022 | -26.85M |
| September 30, 2022 | -40.02M |
| June 30, 2022 | -62.07M |
| March 31, 2022 | -68.74M |
| December 31, 2021 | -71.00M |
| September 30, 2021 | -68.27M |
| June 30, 2021 | -63.83M |
| March 31, 2021 | -53.20M |
| December 31, 2020 | -40.60M |
| September 30, 2020 | -27.91M |
| June 30, 2020 | -23.59M |
| March 31, 2020 | -21.85M |
| December 31, 2019 | -19.40M |
| September 30, 2019 | -20.19M |
| June 30, 2019 | -13.15M |
| Date | Value |
|---|---|
| March 31, 2019 | -6.680M |
| December 31, 2018 | -3.692M |
| September 30, 2018 | -3.782M |
| June 30, 2018 | 15.91M |
| March 31, 2018 | 14.49M |
| December 31, 2017 | 12.56M |
| September 30, 2017 | 11.40M |
| June 30, 2017 | -11.16M |
| March 31, 2017 | -13.13M |
| December 31, 2016 | -14.61M |
| September 30, 2016 | -14.43M |
| June 30, 2016 | -12.83M |
| March 31, 2016 | -10.83M |
| December 31, 2015 | -10.18M |
| September 30, 2015 | -10.60M |
| June 30, 2015 | -15.89M |
| March 31, 2015 | -16.38M |
| December 31, 2014 | -15.52M |
Free Cash Flow Range, Past 5 Years
-71.00M
Minimum
Dec 2021
-13.15M
Maximum
Jun 2019
-38.08M
Average
-30.68M
Median
Dec 2023
Free Cash Flow Benchmarks
| Imunon Inc | -19.47M |
| iBio Inc | -18.89M |
| Kodiak Sciences Inc | -195.61M |
| Petros Pharmaceuticals Inc | -7.626M |
| Ocugen Inc | -65.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.766M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow Per Share (Quarterly) | -3.45 |
| Free Cash Flow to Equity (Quarterly) | -2.766M |
| Free Cash Flow to Firm (Quarterly) | -2.766M |
| Free Cash Flow Yield | -1.17K% |